Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |